FDA Investigator Finn A Slizza

Finn A Slizza has inspections in 3 countries as of 27 Oct 2023. Finn A Slizza has collaborated with a combinined 2365 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Germany, France
A Williams, Aaron J Adler, Abraham M Maekele, Ademola O Daramola, Albert Rodriguez, Alexandria L Capuano, Allen F Hall, Anderson, Angela Shepas, Angelica G Aziz, Arsen Karapetyan, Bichsa T Tran, Burnsb, Carla J Lundi, Carr Sharpe, CDR Sean T Creighton, Celena Ngo, Charles L Larson, Chelsea N Sealey, Cheryl D Mccall, Chong Ming Cheng, Chorng M Cheng, Christian D Lynch (CDL), Christopher M Jenner, Cynthia L Gorveatt, Dannie E Rowland, Darren S Brown, Deborah A Greco, Dejon N Harris, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Donna Ltartaglino Besone, Dr. Guang Gao, PhD, Durell L Giles, Elkins, Esther B Gamallo Herrera, F Alex Slizza, Finn Sizza (Alex), Francis J Eng, Garciam, Gary L Zaharek, Gene D Arcy, Geraldine M Peregrin, Harperd, Herminio C Francisco, Jacqueline C Sram, James A Lane, James E Bentson, James P Stallings, James R Fleckenstein, James R Montero, Janet Pulver, Jasmine N Thompson, Jenny L Chisem, Jenny L Mccardell, Jinnie Kokiatkulkij, Jocelyn E Massey, Jocelyn E Sparks, Joey V Quitania, John A Gonzalez, Joshua J Silvestri, Juanita Banuelos, Judy C Nepsa, Kaarin M Slotte, Kari M Johansen, Katherine E Jacobitz, Kelvin Cheung, Kevin N Tran, Kham Phommachanh, Kirtida Patel, Lanita F Kelley, Laverne Kimble, Leighton K Ngai, Leo J Lagrotte, Leonard H Lavi, Lilly O Barton, Liming Zhang, Linda Linhn Adams, Linda Thai, M Jasnethoson Thompson, Maria Isabetejerodel Rio, Mariza M Jafary, Mark C Saale, Mary Ewilkerson Brinsko, Matthew M Vernon, Mei Chen Mu, Miaja Umaedi, Michael D Garcia, Michael Garcia, Michael S Araneta, Minh D Phan, Naveen B Walker, Norman Wong, Omotunde I Osunsanmi, Omotunde O Osunsanmi, Paquita F Segarra, Paula A Trost, Prabhu P Raju, Rafael A Kaup, Richard K Vogel, Richard W Tubb, Richmond K Yip, Santiago Gallardo Johnson, Sara Jdent Acosta, Scott K Zika, Selene T Torres, Shaquenta Y Perkins, Sharon I Gundersen, Sonya L Karsik, Steven E Porter, Jr, Sumit Sen, Sunitha K Rajaram, PhD, Suzie L Kent, Tamala P Magee, Terrance L Thomas, Thanh M Andrews, Thao T Kwan, Theresa Kirkham (NMI), Thomas R Beilke, Trang N Cox, Travis S Bradley, Trudy Papson, Trudy R Papson, Truong Xuan Nguyen (Andy), Uros V Djekic, PhD, Urus V Djckik, Vasant G Malshet, PhD, Vashti E Bocker, Vickie L Anderson, Victor H Loo, Virgilio F Pacio, CSO, William S Vitale, Wr Bowman, Yvette E Guillermo, Yvette Mlacour Davis, Zachary L Miller

Finn A Slizza's Documents

Publish Date Document Type Title
August, 2000 FDA 483 CareFusion 303, Inc. - Form 483, 2000-08-04
November, 2000 FDA 483 Response Medline Industries, Inc. - Form 483R, 2001-04-12
April, 2003 EIR Abbott Vascular - EIR, 2003-04-16
January, 2002 EIR Avi Corp - EIR, 2002-01-11
April, 2000 EIR NAMSA, LLC - EIR, 2000-04-27
November, 2000 EIR Medline Industries, Inc. - EIR, 2000-11-03
August, 2000 EIR CareFusion 303, Inc. - EIR, 2000-08-04

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more